Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Pharmerging Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Pharmaceutical
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Patented Prescription Drugs
6.1.2.2 Generic Prescription Drugs
6.1.2.3 OTC Drugs
6.1.3 Market Forecast
6.2 Healthcare
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Medical Devices
6.2.2.2 Clinical Diagnosis
6.2.2.3 Others
6.2.3 Market Forecast

7 Market Breakup by Indication
7.1 Lifestyle Diseases
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cancer and Autoimmune Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Country
9.1 Tier I
9.1.1 China
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.2 Tier II
9.2.1 India
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Brazil
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 Russia
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Africa
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.3 Tier III
9.3.1 Argentina
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Mexico
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 Poland
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Ukraine
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Turkey
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Saudi Arabia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Egypt
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.3.8 Algeria
9.3.8.1 Market Trends
9.3.8.2 Market Forecast
9.3.9 Nigeria
9.3.9.1 Market Trends
9.3.9.2 Market Forecast
9.3.10 Thailand
9.3.10.1 Market Trends
9.3.10.2 Market Forecast
9.3.11 Indonesia
9.3.11.1 Market Trends
9.3.11.2 Market Forecast
9.3.12 Pakistan
9.3.12.1 Market Trends
9.3.12.2 Market Forecast
9.3.13 Others
9.3.13.1 Market Trends
9.3.13.2 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Sanofi S.A.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Pfizer Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 AstraZeneca Plc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 GlaxoSmithKline Plc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 F. Hoffmann-La Roche AG (Roche AG)
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Abbott Laboratories
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Teva Pharmaceutical Limited
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financial
13.3.10.4 SWOT Analysis



List of Figures

Figure 1: Global: Pharmerging Market: Major Drivers and Challenges
Figure 2: Global: Pharmerging Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Pharmerging Market: Breakup by Product (in %), 2022
Figure 4: Global: Pharmerging Market: Breakup by Indication (in %), 2022
Figure 5: Global: Pharmerging Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Pharmerging Market: Breakup by Country (in %), 2022
Figure 7: Global: Pharmerging Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Pharmerging (Pharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Pharmerging (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Pharmerging (Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Pharmerging (Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Pharmerging (Lifestyle Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Pharmerging (Lifestyle Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Pharmerging (Cancer and Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Pharmerging (Cancer and Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Pharmerging (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Pharmerging (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Pharmerging (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Pharmerging (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Pharmerging (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Pharmerging (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Pharmerging (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Pharmerging (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Pharmerging (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Pharmerging (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Pharmerging (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Pharmerging (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Tier I: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Tier I: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: China: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: China: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Tier II: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Tier II: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: India: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: India: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Brazil: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Brazil: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Russia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Russia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Africa: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Africa: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Tier III: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Tier III: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Argentina: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Argentina: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Mexico: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Mexico: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Poland: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Poland: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Ukraine: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Ukraine: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Turkey: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Turkey: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Saudi Arabia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Saudi Arabia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Egypt: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Egypt: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Algeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Algeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Nigeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Nigeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Thailand: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Thailand: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Indonesia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Indonesia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Pakistan: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Pakistan: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Global: Pharmerging Industry: SWOT Analysis
Figure 71: Global: Pharmerging Industry: Value Chain Analysis
Figure 72: Global: Pharmerging Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Pharmerging Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Pharmerging Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Pharmerging Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 4: Global: Pharmerging Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Pharmerging Market Forecast: Breakup by Country (in Million US$), 2023-2028
Table 6: Global: Pharmerging Market: Competitive Structure
Table 7: Global: Pharmerging Market: Key Players